The RX monza is a compact, semi-automated, clinical chemistry analyser for routine and specialised diagnostic testing with an ever expanding test menu, now including HbA1c.

BASINGSTOKE, UK (January 26, 2010) – Oxoid, a world leading microbiology brand, today announced that the Oxoid range of products for antimicrobial susceptibility testing (AST) includes all products recommended by EUCAST (the European Committee on Antimicrobial Susceptibility Testing) for use in the new, harmonized European disc diffusion method, due for launch in 2010. 

Randox laboratories are a primary manufacturer of true 3rd party quality control serum. 

Randox produce quality controls that guarantee a truly independent performance assessment for diagnostic devices, methods and reagents.  Randox controls are not biased or optimised to work with any specific instrument or reagent so are truly 3rd party.

Myconostica Ltd, a UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces that it has received a license from Health Canada for the sale of MycAssayTM Aspergillus.

Oxford, UK and Marlborough, MA; January 7th 2010 – Oxford Immunotec Ltd, the world leading
manufacturer and marketer of T Cell based diagnostic tests, has today announced the election of Dr. Peter
Klemm, President and CEO of Predictive Biosciences, as a Non-Executive Director and the appointment of
Frank Vandeputte as Vice President, Sales and Marketing.